A single dose of Johnson & Johnson’s Covid 19 ‘vaccine is said to be very effective. The FDA’s independent advisors will discuss it on Friday, after which a final decision can be taken on its use. That is, the FDA is just one step away from allowing the third vaccine of Kovid 19 for America.
Johnson & Johnson’s single dose Covid-19 vaccine is scheduled to be discussed by the Food and Drug Administration or FDA’s independent advisors on Friday, on the basis of which its use may be allowed within a few days. Explain that FDA scientists have confirmed that this vaccine has about 66 percent efficacy to prevent infection with moderate to severe levels of Kovid-19.
The same dose of Johnson & Johnson vaccine is effective.
Giving more information about this, FDA said that this vaccine of Johnson & Johnson would need to be given only one dose instead of two and it is safe to use. The FDA is just one step away from allowing a third vaccine for the US.
On Friday, the agency’s independent advisors will discuss whether sufficiently convincing evidence is available to allow this vaccine, based on the advice that the FDA is expected to make a final decision within a few days.
Third vaccine will be approved soon in America
With this, it is being said that the third vaccine of Corona in America will be approved soon. At the same time, tell that about 4.45 crore people in the US have received at least one dose of the vaccine manufactured by Pfizer or Moderna. At the same time, two crore people have received the second dose.
Nidhi Malviya is fun loving girl. She writes at NoobFeeds about various topics related to Finance, Technology, Business etc.